Drugmakers call for evidence-based approach to new drug pricing policy
Published: 2010-02-26 06:59:00
Updated: 2010-02-26 06:59:00
The so-called positive list system reinforces the government's rash approach to shaping policies, according to a joint statement issued by the Korea Pharmaceutical Manufacturers Association (KPMA) and the Korean Research-based Pharmaceutical Industry Association on February 23.
The statement s...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
